China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
23.44
+0.01 (0.04%)
Sep 4, 2026, 3:00 PM CST

SHA:600750 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
640.1709.061,0071,3331,3711,046
Short-Term Investments
-1,233----
Trading Asset Securities
247.2795.110.0150.021,3731,728
Cash & Short-Term Investments
887.372,0381,0171,3832,7442,774
Cash Growth
-47.15%100.28%-26.43%-49.60%-1.07%33.30%
Accounts Receivable
583.3851.49940.69637.79775.45793.54
Other Receivables
21.9526.1116.2964.8743.2648.05
Receivables
605.26877.6956.99702.66818.71841.6
Inventory
408.22454.08460.97487.86386.9377.99
Prepaid Expenses
-----3.88
Other Current Assets
1,06859.1652.2753.08104.6467.24
Total Current Assets
2,9683,4282,4882,6274,0544,064
Property, Plant & Equipment
1,9341,8881,7141,6321,5201,220
Long-Term Investments
128.83930.431,7281,597174.94158.76
Goodwill
52.3752.3741.7441.7441.7441.74
Other Intangible Assets
414.97424.03397.29408.87379.07395.55
Long-Term Deferred Tax Assets
75.8861.0169.2961.1544.4544.9
Long-Term Deferred Charges
15.616.44.064.662.322.77
Other Long-Term Assets
1,14890.6865.9329.0559.0268.97
Total Assets
6,7386,8816,5086,4016,2765,998

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
588.31437.52162.75197.1236.81205.72
Accrued Expenses
80.39850.95983.21856.31813.14692.73
Current Portion of Long-Term Debt
1.46-----
Current Portion of Leases
-1.440.461.251.991.7
Current Income Taxes Payable
97.7844.0857.5848.0919.7712.63
Current Unearned Revenue
78.83192.36288.48293.44358.66299.95
Other Current Liabilities
921.5379.27278.71305.91247.33103.83
Total Current Liabilities
1,7681,9061,7711,7021,6781,317
Long-Term Leases
1.171.170.111.051.182.79
Long-Term Unearned Revenue
91.4883.3790.3349.6167.8573.04
Long-Term Deferred Tax Liabilities
29.1230.8317.8920.1221.5922.72
Other Long-Term Liabilities
156.79156.79156.79---
Total Liabilities
2,0472,1782,0361,7731,7681,415

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
635.61634.95629.02629.36629.58630
Additional Paid-In Capital
483471.29383.02469.65427.35407.82
Retained Earnings
2,9333,0012,8562,8272,8783,008
Treasury Stock
-93-84.63-5.72-16.42-31.5-43.28
Total Common Equity
3,9594,0233,8633,9103,9044,003
Minority Interest
731.98680.29608.83718.76604.41579.45
Shareholders' Equity
4,6914,7034,4724,6294,5084,582
Total Liabilities & Equity
6,7386,8816,5086,4016,2765,998

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.632.610.562.33.164.49
Net Cash (Debt)
884.742,0351,0171,3812,7412,769
Net Cash Growth
-47.23%100.13%-26.35%-49.63%-1.02%33.08%
Net Cash Per Share
1.403.211.611.924.354.38
Filing Date Shares Outstanding
633.82637.71636.1984.26625.4623.7
Total Common Shares Outstanding
633.82637.71636.1984.26625.4623.7
Working Capital
1,2001,523716.43924.442,3772,748
Book Value Per Share
6.256.316.073.976.246.42
Tangible Book Value
3,4923,5463,4243,4593,4833,566
Tangible Book Value Per Share
5.515.565.383.515.575.72
Buildings
-1,6421,5571,5151,0831,059
Machinery
-1,2111,1331,030879.7796.66
Construction In Progress
-208.1599.3170.9445.67190.77